全球定序耗材市場規模、佔有率、趨勢及成長分析報告（2026-2034）

預計定序耗材市場規模將從 2025 年的 112.9 億美元成長到 2034 年的 742.1 億美元，2026 年至 2034 年的複合年成長率為 23.27%。

隨著基因組研究和個人化醫療的進步不斷推動對定序技術的需求，定序耗材市場預計將迎來顯著成長。定序耗材包括用於DNA和RNA定序過程的試劑、試劑盒和其他材料，對於研究、臨床診斷和生物技術領域的各種應用至關重要。隨著高通量定序和基因組分析需求的持續成長，定序耗材市場預計將大幅擴張。

定序技術和調查方法的進步在塑造定序耗材市場方面發揮關鍵作用。次世代定序(NGS) 和單細胞定序的創新提高了基因組分析的效率和準確性，使定序耗材對研究人員和醫療保健機構更具吸引力。此外，個人化醫療和標靶治療的興起也推動了對能夠實現精準基因組分析和診斷的耗材的需求。隨著製造商持續加大研發投入，新型耗材產品和應用的潛力將進一步推動定序耗材市場的成長。

此外，人們對健康和保健日益成長的關注正在影響定序耗材市場的格局。隨著消費者和醫療保健專業人員尋求了解遺傳易感性並進行相應治療，對定序技術和耗材的需求不斷成長。許多研究和臨床檢查室正在採用先進的定序方法，旨在改善患者照護和健康結果。將定序耗材整合到更廣泛的醫療保健實踐中將進一步提升其吸引力。隨著市場的成熟，技術、健康趨勢和消費者偏好的整合將成為成長的關鍵驅動力，使定序耗材成為現代基因組研究和診斷的重要組成部分。

目錄

第1章 引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 繪製滲透率和成長前景圖
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 市場問題
• 波特五力分析
• PESTLE分析

4. 全球定序耗材市場（依產品分類）

• 市場分析、洞察與預測
• 成套工具
• 試劑
• 配件

5. 全球定序耗材市場（依平台分類）

• 市場分析、洞察與預測
• 第一代定序耗材
• 第二代定序耗材
• 第三代定序耗材

6. 全球定序耗材市場（依應用領域分類）

• 市場分析、洞察與預測
• 癌症診斷
• 感染疾病診斷
• 生殖健康檢查
• 藥物基因體學
• 農業基因組學
• 其他

7. 全球定序耗材市場（依最終用途分類）

• 市場分析、洞察與預測
• 製藥和生物技術公司
• 醫院和研究機構
• 學術研究機構
• 其他

8. 全球定序耗材市場（依地區分類）

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商格局（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Hoffmann-La Roche Ltd
  • Qiagen
  • Agilent Technologies
  • Millipore Sigma
  • Takara Bio Inc
  • Beckman Coulter Inc
  • Eurofins Genomics
  • Oxford Nanopore Technologies Ltd
  • Thermo Fisher Scientific Inc
  • BGI Genomics

The Sequencing Consumables Market size is expected to reach USD 74.21 Billion in 2034 from USD 11.29 Billion (2025) growing at a CAGR of 23.27% during 2026-2034.

The Sequencing Consumables market is poised for significant growth as advancements in genomic research and personalized medicine continue to drive demand for sequencing technologies. Sequencing consumables, which include reagents, kits, and other materials used in DNA and RNA sequencing processes, are essential for various applications in research, clinical diagnostics, and biotechnology. As the demand for high-throughput sequencing and genomic analysis continues to rise, the sequencing consumables market is expected to expand significantly.

Technological advancements in sequencing technologies and methodologies are playing a crucial role in shaping the Sequencing Consumables market. Innovations in next-generation sequencing (NGS) and single-cell sequencing are enhancing the efficiency and accuracy of genomic analysis, making sequencing consumables more appealing to researchers and healthcare providers. Additionally, the rise of personalized medicine and targeted therapies is driving demand for consumables that enable precise genomic profiling and diagnostics. As manufacturers continue to invest in research and development, the potential for new consumable products and applications will drive growth in the sequencing consumables market.

Moreover, the increasing focus on health and wellness is influencing the Sequencing Consumables market landscape. As consumers and healthcare professionals seek to understand genetic predispositions and tailor treatments accordingly, the demand for sequencing technologies and consumables is rising. Many research institutions and clinical laboratories are adopting advanced sequencing methods to enhance patient care and improve health outcomes. The integration of sequencing consumables into broader healthcare initiatives will further enhance their appeal. As the market matures, the convergence of technology, health trends, and consumer preferences will be key drivers of growth, positioning sequencing consumables as essential components in modern genomic research and diagnostics.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Kits
• Reagents
• Accessories

By Platform

• 1st Generation Sequencing Consumables
• 2nd Generation Sequencing Consumables
• 3rd Generation Sequencing Consumables

By Application

• Cancer Diagnostics
• Infectious Disease Diagnostics
• Reproductive Health Diagnostics
• Pharmacogenomics
• Agrigenomics
• Others

By End-use

• Pharmaceutical and Biotechnology Companies
• Hospitals and Laboratories
• Academic Research Institutes
• Others

COMPANIES PROFILED

• HoffmannLa Roche Ltd, Qiagen, Agilent Technologies, Millipore Sigma, Takara Bio Inc, Beckman Coulter Inc, Eurofins Genomics, Oxford Nanopore Technologies Ltd, Thermo Fisher Scientific Inc, BGI Genomics

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SEQUENCING CONSUMABLES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Accessories Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SEQUENCING CONSUMABLES MARKET: BY PLATFORM 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Platform
• 5.2. 1st Generation Sequencing Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. 2nd Generation Sequencing Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. 3rd Generation Sequencing Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SEQUENCING CONSUMABLES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Cancer Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Infectious Disease Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Reproductive Health Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Pharmacogenomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Agrigenomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SEQUENCING CONSUMABLES MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Pharmaceutical and Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Hospitals and Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Academic Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL SEQUENCING CONSUMABLES MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Platform
  • 8.2.3 By Application
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Platform
  • 8.3.3 By Application
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Platform
  • 8.4.3 By Application
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Platform
  • 8.5.3 By Application
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Platform
  • 8.6.3 By Application
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL SEQUENCING CONSUMABLES INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Hoffmann-La Roche Ltd
  • 10.2.2 Qiagen
  • 10.2.3 Agilent Technologies
  • 10.2.4 Millipore Sigma
  • 10.2.5 Takara Bio Inc
  • 10.2.6 Beckman Coulter Inc
  • 10.2.7 Eurofins Genomics
  • 10.2.8 Oxford Nanopore Technologies Ltd
  • 10.2.9 Thermo Fisher Scientific Inc
  • 10.2.10 BGI Genomics